Literature DB >> 23580432

The roles of aryl hydrocarbon receptor in immune responses.

Nam Trung Nguyen1, Hamza Hanieh, Taisuke Nakahama, Tadamitsu Kishimoto.   

Abstract

A number of recent studies have examined the functions of aryl hydrocarbon receptor (Ahr) in the immune system. Also known as dioxin receptor, Ahr is a ligand-activated transcription factor that serves as a receptor for various environmental toxins. The functions of Ahr in T cells depend on the specific ligand bound to the receptor. For instance, binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to Ahr suppresses experimental autoimmune encephalomyelitis (EAE) by promoting the development of Foxp3(+) Treg cells, whereas 6-formylindolo[3,2-b]carbazole enhances EAE by inducing the differentiation of IL-17-producing T cells. Furthermore, specifically deleting Ahr in T cells inhibits collagen-induced arthritis in mice. In macrophages and dendritic cells (DCs), Ahr is anti-inflammatory. In response to LPS, Ahr-deficient macrophages show increased production of pro-inflammatory cytokines, such as IL-6 and TNF-α, and Ahr-deficient DCs produce less of the anti-inflammatory cytokine IL-10. In this review, we discuss the roles of Ahr in macrophages and T cells. Moreover, studies examining Ahr activation in other cell types have revealed additional contributions to B cell and osteoblast/osteoclast differentiation. We also briefly summarize the current understanding of regulatory mechanisms underlying Ahr activation in various cells and discuss the potential clinical implications of cell-specific targeting of Ahr in pathologic conditions of the immune system.

Entities:  

Keywords:  dioxin receptor; immune regulation

Mesh:

Substances:

Year:  2013        PMID: 23580432     DOI: 10.1093/intimm/dxt011

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  63 in total

1.  Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Iain A Murray; Seokwon Lee; Haley F Hazlett; Gary H Perdew; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2017-03-20       Impact factor: 4.219

2.  The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells.

Authors:  Jian Ye; Ju Qiu; John W Bostick; Aki Ueda; Hilde Schjerven; Shiyang Li; Christian Jobin; Zong-Ming E Chen; Liang Zhou
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

3.  AhR activation increases IL-2 production by alloreactive CD4+ T cells initiating the differentiation of mucosal-homing Tim3+ Lag3+ Tr1 cells.

Authors:  Allison K Ehrlich; Jamie M Pennington; Susan Tilton; Xisheng Wang; Nikki B Marshall; Diana Rohlman; Castle Funatake; Sumit Punj; Edmond O'Donnell; Zhen Yu; Siva K Kolluri; Nancy I Kerkvliet
Journal:  Eur J Immunol       Date:  2017-09-15       Impact factor: 5.532

4.  Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase.

Authors:  Hsueh-Chun Wang; Tzu-Hsuan Wong; Li-Ting Wang; Hsiang-Han Su; Hsiu-Yueh Yu; Ai-Hsuan Wu; Yu-Chun Lin; Hua-Ling Chen; Jau-Ling Suen; Shih-Hsien Hsu; Li-Chen Chen; Yufeng Zhou; Shau-Ku Huang
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

5.  Aryl hydrocarbon receptor promotes lipid droplet biogenesis and metabolic shift in respiratory Club cells.

Authors:  Hsueh-Chun Wang; Kwei-Yan Liu; Li-Ting Wang; Shih-Hsien Hsu; Shao-Chun Wang; Shau-Ku Huang
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

6.  Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense.

Authors:  Taisho Yamada; Hiromasa Horimoto; Takeshi Kameyama; Sumio Hayakawa; Hiroaki Yamato; Masayoshi Dazai; Ayato Takada; Hiroshi Kida; Debbie Bott; Angela C Zhou; David Hutin; Tania H Watts; Masahiro Asaka; Jason Matthews; Akinori Takaoka
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

7.  Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor.

Authors:  June Ho Shin; Luhua Zhang; Oihana Murillo-Sauca; Junmo Kim; Holbrook E K Kohrt; Jack D Bui; John B Sunwoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

Review 8.  Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.

Authors:  J Chang; A E Hakam; L K McCauley
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 9.  The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.

Authors:  Nicholas Dopkins; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

10.  Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.

Authors:  Joel Kaye; Victor Piryatinsky; Tal Birnberg; Tal Hingaly; Emanuel Raymond; Rina Kashi; Einat Amit-Romach; Ignacio S Caballero; Fadi Towfic; Mark A Ator; Efrat Rubinstein; Daphna Laifenfeld; Aric Orbach; Doron Shinar; Yael Marantz; Iris Grossman; Volker Knappertz; Michael R Hayden; Ralph Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.